Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C

Published:2004-12 Issue:6 Volume:31 Page:259-265
ISSN:0960-7420
Container-title:European Journal of Immunogenetics
language:en
Short-container-title:Eur J Immunogenet

Author:

Airoldi A.,Zavaglia C.,Silini E.,Tinelli C.,Martinetti M.,Asti M.,Rossini A.,Vangeli M.,Salvaneschi L.,Pinzello G.

Publisher

Wiley

Subject

Genetics,Immunology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2370.2004.00478.x/fullpdf

Reference43 articles.

1. Risk factors of hepatitis C virus-related liver cirrhosis in young adults: Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2) *0201 Allele

2. Interferon-α Therapy in HCV Hepatitis: HLA Phenotype and Cirrhosis are Independent Predictors of Clinical Outcome

3. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

4. Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection

5. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of LMP7 and TAP2 gene polymorphisms with treatment response to interferon/ribavirin in patients with genotype 1 chronic hepatitis C;International Journal of Molecular Medicine;2017-10-10

2. The pharmacogenetic background of hepatitis C treatment;Mutation Research/Reviews in Mutation Research;2012-07

3. Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C;International Journal of Immunogenetics;2012-01-30

4. HLA Class II Alleles and Chronic Hepatitis C Virus Infection;Scandinavian Journal of Immunology;2011-08-07

5. The role of genetic markers in hepatitis C virus therapy: a major step for individualized care;Liver International;2011-01